Stelmakh Edward 4
4 · OptimizeRx Corp · Filed Dec 22, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Stelmakh Edward
CFO/COO
Transactions
- Exercise/Conversion
Common Stock
2025-12-19+5,237→ 128,218 total - Sale
Common Stock
2025-12-19$13.51/sh−1,388$18,752→ 126,830 total - Exercise/Conversion
Restricted Stock Units
2025-12-19−5,237→ 5,237 totalExp: 2026-12-19→ Common Stock (5,237 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.